Malaria is a global infectious disease that remains a leading cause of morbidity and mortality
in the developing world. Multiple environmental and host and parasite factors govern the …

Vaccines against parasites have lagged centuries behind those against viral and bacterial
infections, despite the devastating morbidity and widespread effects of parasitic diseases …

Viral vectors are a potent vaccine platform for inducing humoral and T-cell immune
responses. Among the various viral vectors, replication-competent ones are less commonly …

The Malaria Vaccine Technology Roadmap 2013 (World Health Organization) aims to
develop safe and effective vaccines by 2030 that will offer at least 75% protective efficacy …

Among Plasmodium spp. responsible for human malaria, Plasmodium vivax ranks as the
second most prevalent and has the widest geographical range; however, vaccine …

The hepatitis E virus (HEV) is a major global health problem, leading to large outbreaks in
the developing world and chronic infections in the developed world. HEV is a non …

We previously demonstrated that boosting with adeno-associated virus (AAV) type 1 (AAV1)
can induce highly effective and long-lasting protective immune responses against malaria …

Merozoite invasion of the erythrocytes in humans is a key step in the pathogenesis of
malaria. The proteins involved in the merozoite invasion could be potential targets for the …

Background: in this report, we describe the case of an 83-year-old woman vaccinated with
ChadOx1 nCoV-19 who developed a so-called vaccine-induced thrombosis with …

Plasmodium falciparum causes malaria through a complex interaction of parasite-induced
changes in red blood cell (RBC), including microcirculatory abnormalities, immunological …